Pfizer Inc PFE:NYSE

Earnings Announcement Next Ex-Dividend date is expected on 01/27/2022
Last Price$52.79NYSE Previous Close - Last Trade as of 7:00PM ET 1/21/22

Today's Change-1.26(2.33%)
Bid (Size)$52.30 (2)
Ask (Size)$52.45 (1)
Day Low / High$52.46 - 54.87
Volume41.1 M
 

View Pharmaceuticals: Major IndustryPeer Comparison as of 01/21/2022

 

Pfizer Inc ( NYSE )

Price: $52.79
Change: -1.26 (2.33%)
Volume: 41.1 M
7:00PM ET 1/21/2022
 
 

Abbvie Inc ( NYSE )

Price: $131.98
Change: -1.05 (0.79%)
Volume: 7.6 M
6:30PM ET 1/21/2022
 
 

Eli Lilly and Co ( NYSE )

Price: $243.06
Change: -0.07 (0.03%)
Volume: 2.8 M
7:00PM ET 1/21/2022
 
 

Merck & Co Inc ( NYSE )

Price: $79.98
Change: -0.77 (0.95%)
Volume: 18.5 M
7:00PM ET 1/21/2022
 
 

Johnson & Johnson ( NYSE )

Price: $164.87
Change: -0.38 (0.23%)
Volume: 10.6 M
7:00PM ET 1/21/2022
 

Read more news Recent News

Pzifer, OPKO Health Evaluating FDA's Complete Response Letter on Growth Hormone Replacement
4:45PM ET 1/21/2022 MT Newswires

Pfizer (PFE) and OPKO Health (OPK) late Friday said they were reviewing the complete response letter issued by the US Food and Drug Administration after...

Moderna's Valuation Has Come 'Back to Earth,' Become More Reasonable, BofA Securities Says
4:16PM ET 1/21/2022 MT Newswires

Moderna's (MRNA) valuation has come "back to earth" and is now more reasonable, after experiencing a rapid increase during the COVID-19 pandemic, BofA...

Market Chatter: Pfizer's COVID-19 Vaccine Gets WHO Backing for Kids Ages 5 to 11
11:18AM ET 1/21/2022 MT Newswires

Pfizer's (PFE) COVID-19 vaccine has been recommended by the World Health Organization for use in children aged 5 to 11, Reuters reported Friday. The...

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Pfizer Inc.
4:45PM ET 1/20/2022 MT Newswires

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as...

Company Profile

Business DescriptionPfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY. View company web site for more details
Address235 East 42nd Street
New York, New York 10017-5755
Phone+1.212.733.2323
Number of Employees92,400
Recent SEC Filing01/14/20224
Chairman, Chief Executive & Operating OfficerAlbert Bourla
President & General Manager-Pfizer VaccinesSusan Silbermann
Chief Financial Officer & EVP-Global SupplyFrank A. D'Amelio
Chief Scientific Officer & Research PresidentMikael Dolsten

Company Highlights

Price Open$54.42
Previous Close$54.05
52 Week Range$33.36 - 61.71
Market Capitalization$296.3 B
Shares Outstanding5.6 B
SectorHealth Technology
IndustryPharmaceuticals: Major
Current Dividend / Yield$0.40 / 3.03%
Dividend Ex-Date01/27/2022
Dividend Pay-Date03/04/2022
Dividend Yield 5 Year Average3.66%
Next Earnings Announcement02/08/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings15.71
Earnings per Share$3.66
Beta vs. S&P 500N/A
Revenue$53.6 B
Net Profit Margin27.26%
Return on Equity27.23%

Analyst Ratings as of 01/20/2022

Buy
11
Overweight
0
Hold
13
Underweight
1
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset